1. ALA698755 F Effective concentration against influenza virus in MDCK cells unidentified influenza virus 5 organism-based format Scientific Literature 2. ALA698756 F Effective concentration against influenza virus in MDCK cells unidentified influenza virus 21 organism-based format Scientific Literature 3. ALA698757 F Inhibition concentration against influenza A (WSN) unidentified influenza virus 2 organism-based format Scientific Literature 4. ALA698758 F Inhibition concentration against influenza B (WSN) unidentified influenza virus 2 organism-based format Scientific Literature 5. ALA698759 F Inhibitory dose of compound required to inhibit cytopathogenic effects of influenza virus with A2/Aichi/2/68 strain in MDCK cells unidentified influenza virus 2 organism-based format Scientific Literature 6. ALA698760 F Tested for inhibition of virus-induced cytopathogenic effect and cytotoxicity of compound against influenza virus with A2/Aichi/2/68 strain in MDCK cell unidentified influenza virus 2 organism-based format Scientific Literature 7. ALA698761 F Cytotoxicity of compound was measured against Influenza virus unidentified influenza virus 5 organism-based format Scientific Literature 8. ALA698762 F Cytotoxicity of compound was measured against Influenza virus;in range of 8-9 unidentified influenza virus 1 organism-based format Scientific Literature 9. ALA698763 F Compound tested for inhibition of influenza virus infectivity in cell culture determined by plaque reduction assay unidentified influenza virus 5 organism-based format Scientific Literature 10. ALA698764 F Compound tested for inhibition of influenza virus infectivity in cell culture determined by plaque reduction assay;Inactive unidentified influenza virus 1 organism-based format Scientific Literature 11. ALA698765 F Concentration required for 50% inhibition of influenza A/WS/33 by plaque reduction assay unidentified influenza virus 5 organism-based format Scientific Literature 12. ALA698766 F Concentration required for 50% inhibition of influenza A/WS/33 by plaque reduction assay; not determined unidentified influenza virus 2 organism-based format Scientific Literature 13. ALA698767 F Inhibitory effect against influenza virus plaque formation at a concentration of 100 uM unidentified influenza virus 4 organism-based format Scientific Literature 14. ALA698768 F Inhibitory effect against influenza virus plaque formation at a concentration of 200 uM unidentified influenza virus 7 organism-based format Scientific Literature 15. ALA878453 F The compound was evaluated for the inhibition of influenza virus (X-31) unidentified influenza virus 3 organism-based format Scientific Literature 16. ALA698769 F Potency to inhibit influenza virus (X-31) relative to alpha-C-allyl sialic acid unidentified influenza virus 3 organism-based format Scientific Literature 17. ALA752574 F Compound was tested for inhibition of Influenza neuraminidase unidentified influenza virus 2 organism-based format Scientific Literature 18. ALA761889 F Minimum inhibitory concentration required to reduce virus induced cytopathogenicity by 50% against para influenza virus in WI-38 cell cultures para influenza virus 6 organism-based format Scientific Literature 19. ALA857966 F Antiviral activity against the HSV-2 MS strain unidentified influenza virus 1 organism-based format Scientific Literature 20. ALA841085 F Antiviral activity against the influenza Ao/PR/8/34 virus strain unidentified influenza virus 4 organism-based format Scientific Literature